Aditxt stock.

Aditxt to Implement 1-for-40 Reverse Stock Split Aug. 17: MT Aditxt, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 Aug. 14: CI Aditxt, Inc. Announces Resignation of Matthew Shatzkes as Chief Legal Officer, General Counsel and Corporate Secretary ...Aditxt (NASDAQ:ADTX) stock is rocketing higher on Thursday despite a lack of news from the biotechnology company. There are no new press releases or filings with the Securities and Exchange ...Nov 30, 2023 · Aditxt (NASDAQ:ADTX) stock is rocketing higher on Thursday despite a lack of news from the biotechnology company. No new press releases or filings with the Securities and Exchange Commission (SEC ... At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune …Aditxt, Inc. has entered into revenue-sharing agreement with Cellvera, and certain of its affiliates. The agreement is designed to drive strategic revenue and growth starting in 2022 and provide enhanced security for the Company's $14.5 million loan, plus interest to Cellvera Global Holdings LLC (“Cellvera”), formerly AiPharma Global Holdings …Aditxt (NASDAQ:ADTX) stock is rocketing higher on Thursday despite a lack of news from the biotechnology company. There are no new press releases or filings with the Securities and Exchange ...

Aditxt (NASDAQ:ADTX) stock price dipped 48% on the purchase and sale of an aggregate of 1M shares at a purchase price of $10.00 per share in a private placement priced at the market under Nasdaq ...Stock Quote; SEC Filings; Corporate Governance; Frequently Asked Questions; Media Room. News; Media Coverage; Interviews; Press Releases; Contact Us

The purpose of this Amendment No. 1 on Form 10-K/A (the “Amendment”) is to amend and restate Part III, Items 10 through 14 of the previously filed Annual Report on Form 10-K of Aditxt, Inc. (the “Company”) for the year ended December 31, 2022, filed with the Securities and Exchange Commission on April 17, 2023 (the “Original Form 10-K”), to …Aditxt, Inc. ADTX shares are blasting higher Thursday despite a lack of company-specific news. Despite today's gains, the stock remains down by more than 20% over the last month. What To Know:The Series A warrants permit the holder to purchase one share of common stock at an exercise price of $9.00 and expire after 5 years. The Series B warrants are exercisable at $11.25 per share.At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

ADTX | Aditxt.com | Innovation in monitoring and treatment of the immune system 14 • For the quarter ended March 31, 2022 Aditxt recognized $210,279 of revenue compared to $105,034 in the year ended December 31, 2022. - - - 79 $-0 0 0 0 0 00 0 1 1 1 1 2 evenue Commercialization

4 days ago ... Cision PR Newswire · Thinking about buying stock in Aditxt Inc, Ampio Pharmaceuticals, TOP SHIPS, Mullen Automotive, or Oatly Group ? · Get News ...

Aditxt climbs 32% postmarket after completing 1-for-50 reverse stock split SA News Tue, Sep. 13, 2022 Aditxt stock surges 61% on positive preclinical toxicity study of its psoriasis drug candidate189,204 Yield ADTX is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend Date N/A Short Interest (10/31/23) Shares Sold Short 959 Change from Last 140.35% Percent of Float... What is Aditxt's Market Cap? ( NASDAQ: ADTX) Aditxt 's market cap is $2.03M, as of Oct 13, 2023. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. Aditxt 's market cap is calculated by multiplying ADTX 's current stock price of $10.65 by ADTX 's total outstanding shares of 190,268.Stock Quote ChartingStock analysis for Aditxt Inc (ADTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,000,000 shares of common stock (or pre-funded warrant in lieu thereof) at a purchase price of $10.00 ... Aditxt, Inc. analysts consensus, targets, ratings and recommendations | Nasdaq: ADTX | NasdaqSep 14, 2022 · ADTX Stock and the Reverse Split. Yesterday afternoon, Aditxt announced that it would carry out “a 1-for-50 reverse split of its common stock” to go into effect yesterday at 4:01 pm Eastern ... Complete Aditxt Inc. stock information by Barron's. View real-time ADTX stock price and news, along with industry-best analysis.Aditxt, Inc. Common Stock (ADTX) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Live Key Data Bid Price and Ask Price The bid & ask refers to the …

Aditxt, Inc. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: ADTX | NasdaqFrequently Asked Questions for Aditxt, Inc. Shareholders Aditxt stock is traded on the Nasdaq Capital Market exchange under the ticker symbol ADTX, and its common stock CUSIP number is 007025505. Aditxt’s initial public offering (IPO) occurred on July 2, 2020. Vstock Transfer, LLC is Aditxt’s transfer agent. Vstock Transfer, LLC18 Lafayette

Investors in Aditxt, Inc. ADTX need to pay close attention to the stock based on moves in the options market lately.That is because the Sep 17, 2022 $2.50 Call had some of the highest implied ...Aditxt Stock Forecast FAQ What is ADTX's revenue growth forecast for 2023-2024? ( NASDAQ : ADTX ) Aditxt 's forecast annual revenue growth rate of 521% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.06% , and it is also forecast to beat the US market's average forecast revenue growth rate of 7.51% .Aditxt Stock Forecast FAQ What is ADTX's revenue growth forecast for 2023-2024? ( NASDAQ : ADTX ) Aditxt 's forecast annual revenue growth rate of 521% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.06% , and it is also forecast to beat the US market's average forecast revenue growth rate of 7.51% .A. While ratings are subjective and will change, the latest Aditxt ( ADTX) rating was a maintained with a price target of $4.00 to $61.00. The current price Aditxt ( ADTX) is trading at is $3.57 ...Supported by clinical researchers, chemists, computer science and biostatisticians teams, the Aditxt platforms will unlock next-level technologies and therapies. These innovations will fuel the frontline work in the fight against diseases.17 Nov 2023 ... Amro Albanna, CEO of Aditxt, Inc., was recently interviewed by Benzinga. Aditxt is an innovation platform commercializing promising ...Aditxt Announces Closing of $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules. Find the latest Aditxt, Inc. (ADTX) stock quote, history, news and other vital information to help you with your stock trading and investing.Additional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on July 20, 2023, as amended. ...Track Aditxt Inc (ADTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

msn.com - September 7 at 4:44 AM. Aditxt Announces Closing of $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules. finance.yahoo.com - September 6 at 6:43 PM. marketbeat.com - September 6 at 9:42 AM. Aditxt (NASDAQ:ADTX) Plummets on $10M Private Placement. msn.com - September 1 at 11:26 PM.

17 thg 8, 2023 ... Aditxt®, Inc. (NASDAQ: ADTX) is a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system ...

Aditxt, Inc. (NASDAQ:ADTX – Get Free Report) was the target of a significant growth in short interest during the month of November. As of November 15th, …Aditxt (NASDAQ:ADTX) stock is rocketing higher on Thursday despite a lack of news from the biotechnology company. There are no new press releases or filings with the Securities and Exchange ...UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT ...Aditxt Announces Closing of $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules. Find the latest Aditxt, Inc. (ADTX) stock quote, history, news and other vital information to help you with your stock trading and investing.Aditxt (NASDAQ:ADTX) stock is rocketing higher on Thursday despite a lack of news from the biotechnology company. There are no new press releases or filings with the Securities and Exchange ...Aditxt, Inc. (ADTX) is a global innovation activation company that discovers, develops, and deploys technologies that monitor and modulate the immune system. The stock price, news, quote, history, and research reports of ADTX are available on Yahoo Finance. See the latest updates on its performance outlook, earnings date, dividend yield, and more. Apr 20, 2023 · Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and sale of an aggregate of 1,585,350 shares of common stock (or common ... Supported by clinical researchers, chemists, computer science and biostatisticians teams, the Aditxt platforms will unlock next-level technologies and therapies. These innovations will fuel the frontline work in the fight against diseases.Short interest for Aditxt gives investors a sense of the degree to which investors are betting on the decline of Aditxt's stock. Short interest data is updated every two weeks.

Aditxt, Inc. Stock price Equities ADTX US0070256047 Biotechnology & Medical Research Market Closed ... Aditxt’s monitoring service is based on a comprehensive evaluation of the immune response to the virus or vaccine. AditxtScore provides meaningful information to help understand one’s personal immune response to COVID and not just that of the population collectively. Learn more about what your results mean in this video. From the White ...What percentage of Aditxt stock is owned by insiders? 1.23% of Aditxt stock is owned by insiders. Learn more on ADTX's insider holdings. Which Aditxt insiders have been buying company stock? The following insider purchased ADTX shares in the last 24 months: Amro A Albanna ($0.00).Additional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on August 1, 2022, as amended. About Aditxt, Inc. Aditxt is a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system.Instagram:https://instagram. best mortgage companies in nycure etfleslies pool stockberry global group inc Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt or the “Company”), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, announced today that it will effect a 1-for-40 reverse split of its common stock effective as of 9:30 a.m. Eastern … best options trading strategyxbox 360 worth used What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the info you need to form an effective investment strategy. So ...Aditxt Stock Performance. ADTX opened at $3.50 on Wednesday. Aditxt has a 12-month low of $3.27 and a 12-month high of $76.40. The stock has a fifty day moving average of $8.52 and a 200-day ... thinkorswim forex Aditxt to Implement 1-for-40 Reverse Stock Split Aug. 17: MT Aditxt, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 Aug. 14: CI Aditxt, Inc. Announces Resignation of Matthew Shatzkes as Chief Legal Officer, General Counsel and Corporate Secretary ...Nov 30, 2023 · Aditxt shares are down from a premarket high of $8.27 and are moving on very heavy trading volume. Aditxt, Inc. ADTX +31.7%. + Free Alerts. shares are blasting higher Thursday despite a lack of ...